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Lymphoma is the most common malignancy of the spleen. The imaging features of splenic lymphoma are nonspeciﬁc and mostly
lymphomas present as a diﬀusely enlarged spleen. Focal lesions are described but remain of low density or intensity on CT or MRI,
respectively. We describe a histologically proven case of splenic lymphoma that showed an atypical hyperdense/hyperenhancing
appearance on imagingsuspicious for avascular pathology. To the best of ourknowledge and based on review of English literature,
such an appearance of splenic lymphoma is extremely unusual and rare.
1.Introduction
Lymphoma is the most common tumor of the spleen and
it may be primary or secondary to a diﬀuse lymphomatous
process [1]. Splenic involvement in lymphoma is important
in deciding the line of treatment and determines the overall
prognosis. Splenic involvement by lymphoma has varied
appearances including the spleen being normal that is
microscopic involvement or splenomegaly with or without
focal mass lesions [2, 3]. Focal involvement is typically
hypodense on noncontrast CT and mildly hyperintense on
T2-weighted MRI with poor postcontrast enhancement on
both [2–4]. Our case is unique in that the splenic lesions of
lymphoma were intensely enhancing on CT and MRI, which
is not typically described or expected on imaging of splenic
lymphoma.
2.CaseReport
A 60-year-old Caucasian male presented to the ER with one-
month history of weakness, fatigue, and left upper quadrant
pain. Past medical history was signiﬁcant for diabetes
Mellitus, hypertension, and hyperlipidemia. Patient worked
in a fertilizing chemical business with history of exposure
to chemicals and pesticides over the last 2 decades. Physical
examination was remarkable for pallor and splenomegaly
extending 7-8cm below costal margin. Laboratory analysis
showed hemoglobin of 9g/dL, hematocrit 28%, white count
4.0 ×103/mm3,andplateletcountof70 ×103/µL.Peripheral
blood smear did not show any abnormal lineage cells.
NoncontrastCTabdomen showedmassivesplenomegaly
with multiple hyperdense foci within the spleen (Figure 1,
arrowheads) representing hemorrhage within the splenic
parenchyma. Post contrast CT (Figure 2) revealed multifocal
intensely enhancing areas in the splenic parenchyma sug-
gesting the highly vascular nature of these masses. Diﬀer-
ential diagnoses based on these ﬁndings included atypical
hemangioma, splenic peliosis, and angiosarcoma [4, 5]. MRI
revealed massive splenomegaly with multifocal cystic areas,
which showed evidence of variable sized blood products. On
postcontrast MRI, there was central enhancement of these
lesions (Figure 3) with intralesional traversing blood vessels
(not shown). Prospective diagnosis based on MR ﬁndings
was splenic peliosis with giant cavernous hemangioma being
a close second possibility.
Bone marrow biopsy, however, revealed a B-cell lym-
phoma and an initial staging PET scan showed massively
enlarged spleen with increased FDG uptake (Figure 4)
with an SUV of 6.23 consistent with lymphoma or other
malignant process [3, 6]. A week after the presentation, the2 Case Reports in Oncological Medicine
Figure 1: Axial noncontrast CT section through the abdomen
showing splenomegaly with multiple hyperdense nodules in the
splenic parenchyma (arrowheads).
Figure 2: Lesions showing intense enhancement on post contrast
CT images.
patient presented in ER with splenic rupture and underwent
emergent splenectomy, splenic pathology showed diﬀuse
large B cell lymphoma.
3. Discussion
CT is the most widely used and currently the imaging
modality of choice for assessment of lymphoma. The overall
accuracy of CT in depicting splenic lymphoma is approxi-
mately 22–65% [3], diﬀerences between series may be partly
explained by advances in multidetector imaging allowing
greater spatial resolution and acquisition during optimal
splenic enhancement. When focal splenic involvement is
detected, deposits are of lower attenuation than adjacent
normal splenic parenchyma on unenhanced CT and demon-
strate little or no enhancement following injection of
intravenous iodinated contrast medium [3, 7]. The lym-
phomatous deposits in spleen in our case were hyperdense
on noncontrast CT with signiﬁcant enhancement following
administration of contrast.
Figure 3: Coronal postcontrast MR image showing splenomegaly
with multiple intensely enhancing masses.
Figure 4: Axial PET CT image showing FDG uptake in the lesions
suggestive of high metabolic activity.
Conventional T1- and T2-weighted MR sequences have
poor sensitivity for splenic involvement in lymphoma, which
is due to the similar relaxation times of lymphoma and
normal splenic tissue using these sequences [8]. Identiﬁable
foci within the spleen are hypointense and hyperintense on
T1- and T2-weighted sequences, respectively. Gadolinium-
enhanced MRI increases conspicuity of lymphoma deposits
as a consequence of their relatively poor enhancement
compared to normal splenic parenchyma [9, 10]. In our
case, the MRI showed multifocal blood, ﬁlled cystic areas of
variable age with marked enhancement postcontrast.
ThediﬀerentialdiagnosesbasedonCTandMRIimaging
characteristics involved pathologies with a high vascular
content, namely, splenic peliosis, cavernous atypical heman-
gioma, or an angiosarcoma. The bone marrow biopsy
obtained given the history of chemical exposure and the
ﬁnding of pancytopenia, however, showed B cell lymphoma.
This was conﬁrmed by PET scan (SUV 6.23) and splenic
pathology when patient presented with a splenic rupture.
In a study of 68 patients with known malignant disease, an
SUV threshold of 2.3 correctly diﬀerentiated benign from
malignant lesions with the sensitivity, speciﬁcity, PPV, and
NPV of 100%, 100%, 100%, and 100%, respectively [6].Case Reports in Oncological Medicine 3
In conclusion, splenic lymphoma could present with
imaging features simulating a vascular malformation or
tumor and should be considered in diﬀerential of a multi-
focal hypervascular lesion, in an appropriate clinical setting.
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